Company Filing History:

12 out of 4,177

Abbott Laboratories Corporation

Years Active: 1997-2015

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9006275 - Compounds as cannabinoid receptor ligands and uses thereof (2015-04-14),

2. 8841334 - Compounds as cannabinoid receptor ligands and uses thereof (2014-09-23),

3. 8546583 - Compounds as cannabinoid receptor ligands and uses thereof (2013-10-01),

4. 7875639 - Compounds as cannabinoid receptor ligands and uses thereof (2011-01-25),

5. 7332504 - Heterocyclic substituted aminoazacycles useful as central nervous system agents (2008-02-19),

6. 7265115 - Diazabicyclic CNS active agents (2007-09-04),

7. 6833370 - Heterocycle substituted aminoazacycles useful as central nervous system agents (2004-12-21),

8. 6437138 - 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission (2002-08-20),

9. 6403575 - 3-Pyridyl enantiomers and their use as analgesics (2002-06-11),

10. 6133253 - 3-Pyridyl enantiomers and their use as analgesics (2000-10-17),

11. 6127386 - 3-Pyridyloxymethyl heterocyclic ether compounds useful in controlling (2000-10-03),

12. 6001849 - Furopyridine, thienopyridine pyrrolopyridine useful in controlling (1999-12-14),

13. 5948793 - 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling (1999-09-07),

14. 5733912 - 7A-heterocycle substituted hexahydro-1H-pyrrolizine compounds useful in (1998-03-31),

15. 5629325 - 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling (1997-05-13),

Title: Keith Brian Ryther: Innovator in Cannabinoid Research

Introduction

Keith Brian Ryther is a notable inventor based in Round Lake Park, Illinois, with a significant contribution to the field of cannabinoid research. He holds a total of 15 patents, showcasing his innovative approach to developing compounds that interact with cannabinoid receptors. His work has implications for treating various medical conditions and disorders.

Latest Patents

Among his latest patents, Ryther has developed compounds that serve as cannabinoid receptor ligands. These inventions include formulations that consist of specific compounds, their pharmaceutical salts, prodrugs, and combinations thereof. The patents detail methods for treating conditions and disorders using these compounds and compositions, highlighting their potential therapeutic applications.

Career Highlights

Throughout his career, Ryther has worked with prominent companies in the pharmaceutical industry, including Abbott Laboratories Corporation and AbbVie Inc. His experience in these organizations has contributed to his expertise in cannabinoid research and development.

Collaborations

Ryther has collaborated with notable colleagues such as Nan-Horng Lin and Mark W Holladay, further enhancing the scope and impact of his research in cannabinoid receptor ligands.

Conclusion

Keith Brian Ryther's contributions to cannabinoid research through his patents and collaborations reflect his dedication to advancing medical science. His innovative work continues to pave the way for new treatments and therapies in the field.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.